Suzanne Rivera named new VP for research

Provost W.A. "Bud" Baeslack III announced, on November 4th, the appointment of Suzanne M. Rivera as Case Western Reserve´s new vice president for research, effective this month. Rivera, the university´s associate vice president for research since January 2011, emerged as the top choice after an extensive process involving campuswide nominations of internal university candidates. Since coming to CWRU, Rivera has distinguished herself through a commitment to collaboration and a focus on systems and processes.
Read more about her.


Research Matters

Click here to view previous editions of Research Matters and Research News and Updates.




Latest News

Research Newsletter
December 9, 2014  

FOIA Requests

CWRU researchers who receive requests for information that invoke the Freedom of Information Act (FOIA) should contact the Office of General Counsel. This should be done immediately so the extremely short deadlines under FOIA can be met. General Counsel can work with the faculty member to take steps to protect proprietary or confidential information from grants and protocols prior to the release of the requested information. Individual researchers should not release information without first consulting with the CWRU Office of General Counsel.

For more information, contact the Office of General Counsel at: http://www.case.edu/president/counsel/contactus.html.

 
Pilot Grants Available from CGREAL

The Center for Genetic Research Ethics and Law (CGREAL) is currently accepting applications for pilot projects from Case Western Reserve University and Cleveland Clinic faculty who are interested in developing research on:

  • Ethical, legal, and social issues (ELSI) in the design and conduct of human genetic research, or
  • The translation of research results into clinical medicine, public health, and health policy needs related to genetics.
These grants are designed to support exploratory efforts towards the development of larger scholarly projects or lines of research related to CGREAL’s mission to facilitate interdisciplinary inquiry into the ethical, legal, and social implications of new advances in genetic and genomic science.

Criteria for evaluation will focus on the potential for expanding and enriching the range of perspectives being brought to genetic research ethics and law at CGREAL. Preference will be given to projects that are deemed likely to foster further collaborative research opportunities.

Requests may be made for up to $5,000. Funds may not be used for faculty salary support. Applications are encouraged from Case Western University and Cleveland Clinic faculty at any rank/level.

Applications will be accepted on a rolling basis and funding for awarded seed grants will be available immediately upon project approval.

Interested faculty should contact Aaron Goldenberg (aaron.goldenberg@case.edu or 216-368-8729).

For further information on the Center for Genetic Research Ethics and Law, see http://www.case.edu/med/bioethics/cgreal/ .

 
The Cleveland Area Reliant IRB Review Process

The Cleveland Area Reliant Institutional Review Board (IRB) Review process includes participation by the Case Western Reserve University (CWRU) Social, Behavioral, and Educational Research (SBER) IRB, the Cleveland Clinic (CC) IRB, MetroHealth Medical Center (MHMC) IRB, and University Hospitals Case Medical Center (UHCMC) IRB. The process relies on executed IRB Authorization Agreements (IAA) between the institutions. These agreements document that all applicable human research subjects protection considerations will be made by one Institutional Review Board (IRB), which will be deemed the IRB of record. The IRBs of the other Cleveland area institutions will accept the approval of the IRB of record through the Reliant Review process. The goal is to eliminate duplication of effort and multiple applications for submission of the same protocol, and to encourage scientific collaboration among the affiliated institutions.

What types of studies are eligible for the Reliant Review Process?
Any type of human research study could be eligible for the Reliant Review process. These include but are not limited to investigator-initiated, federally-funded, foundation-supported, industry-sponsored, and non-funded studies.

The fundamental requirement is that a collaborating investigator must be named at each site where the research will occur. It is important for the Principal Investigator at the lead study site to work with the IRB of record throughout the Reliant Review Process to initiate acceptance of IRB approval at each collaborating site.

For further information, contact Kim Volarcik at (216) 368-0134 or kav6@case.edu.

 
Take Advantage of All Pivot Has to Offer

For years, Community of Science (COS) has been recognized around the world for its funding from a wide variety of sources as well as its access to the world’s research community.

CWRU has subscribed to COS's new product, Pivot, which provides you the edge by bringing together the right research opportunities, funding, and people—quickly and easily. It provides global and local connections that strengthen research by exploring new avenues for funding and collaboration—for faculty, staff researchers, and graduate students.

Pivot can:

  • provide access to the most comprehensive global source of funding opportunities;
  • identify research expertise from within or outside of CWRU;
  • foster collaboration by cultivating essential partnerships and alliances; and
  • build strong network connections for future opportunities.
Learn more about how to use all the features Pivot has to offer.

Sign up for a Pivot Webinar: https://refworks.webex.com/refworks/onstage/g.php?p=4&t=m.

Learn to use Pivot via YouTube: http://www.youtube.com/proquestpivot.

 
Research Performance Progress Report Required for Non-SNAP Progress Reports Beginning October 17, 2014

The National Institutes of Health (NIH) currently requires use of the federal wide progress reporting format — known as the RPPR (Research Performance Progress Report) — to submit progress reports for Streamlined Non-competing Award Process (SNAP), fellowship, and multi-year funded awards. In April NIH opened the RPPR for use for all Type 5 Non-SNAP progress reports in anticipation of an October 2014 requirement for RPPR use.

Now, it’s official — all type 5 non-SNAP progress reports submitted on or after October 17, 2014 need to be submitted through the RPPR module of eRA Commons. This announcement is part of NIH’s ongoing transition to requiring the use of the federal government-wide RPPR format for all progress reporting.

NIH’s website on the RPPR provides information on the why, what, and when of the RPPR, with a handy table that lets you know for which types of grants the RPPR is now required, and for which it is still optional.

See more at: http://nexus.od.nih.gov/all/2014/06/30/rppr-required-for-non-snap-progress-reports-beginning-october-17-2014/?utm_source=nexus&utm_medium=email&utm_content=nihupdate&utm_campaign=jun13#sthash.8GUpbgGT.dpuf .

 

If you have news or information that you wish to have included in this update, please send it via e-mail to Tracy Wilson-Holden at tracy.wilson-holden@case.edu no later than 5 pm on the Monday of the week that the update is to be distributed. If you know of individuals who may be interested in receiving this update, please forward this e-mail to them. To subscribe or unsubscribe to Case Research News, email your request to Tora Williams at tora.williams@case.edu.

Please note: At the time of this transmission, all links functioned. However, Case Research News cannot guarantee that the information will not move or be deleted.